Overview

Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma

Status:
Withdrawn
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
Approximately 480 (120 per group) would need to complete the 12 weeks of treatments.
Phase:
Phase 3
Details
Lead Sponsor:
Adamis Pharmaceuticals Corporation
Treatments:
Beclomethasone